SCHEMBL2928131

SCHEMBL2928131

O=Cc1ccc(OCc2ccccc2)c(C(=O)N(Cc2ccccc2)Cc2ccccc2CO)c1

nearest known ligand 0.47

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.47
ALDH1A1 P00352 1/20 0.47
POLB P06746 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
TSHR P16473 3/20 0.40
MAOA P21397 1/20 0.40
MAOB P27338 1/20 0.40
FOLH1 Q04609 1/20 0.40
APP P05067 3/20 0.39
ELANE P08246 3/20 0.39
F2 P00734 1/20 0.39
RAF1 P04049 1/20 0.39
MAP2K1 Q02750 1/20 0.39
PTGER4 P35408 1/20 0.39
PTGER3 P43115 1/20 0.39
PTGER2 P43116 1/20 0.39
TRPM8 Q7Z2W7 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2929421 0.91 KDM4E (0.54) KDM4EALDH1A1POLBL3MBTL1TSHR
SCHEMBL6811278 0.89 KDM4E (0.46) KDM4EALDH1A1POLBL3MBTL1TSHR
SCHEMBL2930961 0.82 TSHR (0.52) KDM4EALDH1A1POLBL3MBTL1TSHR
SCHEMBL2928136 0.81 APP (0.47) KDM4EALDH1A1POLBL3MBTL1APP
SCHEMBL2926924 0.80 PTGER1 (0.51) KDM4EALDH1A1POLBL3MBTL1TSHR
SCHEMBL2932095 0.79 PDK1 (0.51) KDM4EALDH1A1POLBL3MBTL1MAOA
SCHEMBL2933284 0.78 TSHR (0.46) KDM4EALDH1A1TSHRMAOAMAOB
SCHEMBL2932073 0.78 APP (0.49) KDM4EALDH1A1POLBL3MBTL1MAOA
SCHEMBL6805058 0.77 KDM4E (0.47) KDM4EALDH1A1POLBL3MBTL1MAOA
SCHEMBL2932209 0.77 MAOA (0.57) KDM4EALDH1A1POLBL3MBTL1MAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1313731-B1 THIAZOLIDINE DERIVATIVES AND ITS USE AS ANTIFUNGAL AGENT UCB SA (BE) 2010-09-29 EP disclosed
US-6740670-B2 SUCH AS 5-(((3-(N-METHYL-N-PHENYLAMINO)CARBONYL-4-(PHENYL-METHOXY)) -PHENYL)METHYLENE)-4-OXO-2-THIOXO-3-THIAZOLIDINE-ACETIC ACID OXFORD GLYCOSCIENCES (UK) LTD. (GB) 2004-05-25 US disclosed
US-20030216453-A1 Thiazolidine derivatives and its use as antifungal agent OXFORD GLYCOSCIENCES (UK) LTD (GB) 2003-11-20 US disclosed
EP-1313731-A1 THIAZOLIDINE DERIVATIVES AND ITS USE AS ANTIFUNGAL AGENT Oxford GlycoSciences (UK) Limited (GB) 2003-05-28 EP disclosed
WO-2002022612-A1 THIAZOLIDINE DERIVATIVES AND ITS USE AS ANTIFUNGAL AGENT OXFORD GLYCOSCIENCES (UK) LIMITED (GB) 2002-03-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030216453-A1 Thiazolidine derivatives and its use as antifungal agent CYP3A7, TAS2R7, OXSR1 KDM4E 3752/4885ALDH1A1 2527/4885POLB 4579/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.